List view / Grid view
17 July 2014 | By Roche
Roche presented data from two phase II studies investigating whether crenezumab can delay cognitive and functional decline in people with mild-to-moderate Alzheimer’s disease...
15 July 2014 | By Novartis
Novartis announced a collaboration with Banner Alzheimer's Institute on a pioneering clinical study in Alzheimer's disease (AD) prevention...
20 May 2013 | By University of Cambridge
New research establishes nature of malfunction in protein molecules that can lead to onset of dementia...
6 September 2011 | By Evotec AG
Evotec's MAO-B inhibitor in patients with Alzheimer's disease (AD) to be developed...
